ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

13,113Medicare Part D Prescriptions Filled, Including Refills

Rank: 46 out of 910

$482K Total Retail Price of All Prescriptions

Rank: 186 out of 910

548 Patients Receiving at Least One Drug in Part D
89%Patients 65 Years and Older
61% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Arizona
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

12% of this provider’s 548 patients filled at least one prescription for a schedule three drug, compared to an average of 9%.

Risky Drugs to Seniors

2% of this provider’s 11,996 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

19% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$37 was the average price of a prescription from this provider, compared to $61 among peers.

Prescriptions per Patient

24 is the average number of prescriptions (including refills) per patient, compared to an average of 15.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Arizona
SIMVASTATIN 1,391 1,276 1 3
LISINOPRIL 1,211 1,111 2 2
METFORMIN HCL 885 807 3 6
LEVOTHYROXINE SODIUM 655 614 4 1
METOPROLOL TARTRATE 352 336 5 7
OMEPRAZOLE 335 298 6 5
FUROSEMIDE 295 276 7 9
GLIPIZIDE 284 256 8 38
IBUPROFEN 275 255 9 75
ACTOS 274 258 10 86
CLONIDINE HCL 272 264 11 51
RANITIDINE HCL 250 217 12 28
DIOVAN 249 238 13 34
ATORVASTATIN CALCIUM 245 232 14 14
AMLODIPINE BESYLATE 218 207 15 4
PAROXETINE HCL 204 185 16 50
ACETAMINOPHEN-CODEINE 193 163 S3 17 121
ATENOLOL 171 162 18 10
LANTUS 171 141 18 30
JANUVIA 157 146 20 69
ALENDRONATE SODIUM 152 142 21 22
CAPTOPRIL 150 150 22 187
NYSTATIN-TRIAMCINOLONE 144 125 23 281
NAPROXEN 131 120 24 96
LOSARTAN POTASSIUM 131 121 24 15
DICLOFENAC SODIUM 130 123 26 116
GLYBURIDE 125 110 R 27 46
GABAPENTIN 116 102 28 13
POTASSIUM CHLORIDE 110 110 29 18
INSULIN SYRINGE 108 94 30 47
BACLOFEN 106 91 31 100
WARFARIN SODIUM 104 97 32 11
NIFEDIPINE ER 101 94 33 107
CARVEDILOL 99 99 34 36
NORTRIPTYLINE HCL 97 94 35 183
PROAIR HFA 95 78 36 40
FLUTICASONE PROPIONATE 92 85 37 23
ALLOPURINOL 84 84 38 33
NIFEDIAC CC 80 80 39 131
MECLIZINE HCL 78 78 40 229
SPIRONOLACTONE 68 59 41 66
LOVASTATIN 66 64 42 20
PRAZOSIN HCL 64 64 43 297
SPIRONOLACTONE-HCTZ 62 62 44 231
PLAVIX 57 55 45 53
PIOGLITAZONE HCL 53 48 R 46 223
PANTOPRAZOLE SODIUM 52 44 47 27
CARISOPRODOL 50 50 R 48 71
HYDROCHLOROTHIAZIDE 50 50 48 12
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.